27 completed, 6 unknown, 1 active not recruiting, 1 terminated. 35 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 35 | Completed 27, Unknown 6, Active not recruiting 1, Terminated 1 |
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow Colchicine: new trials by email Literature Review of Colchicine trials Research Report on Colchicine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL Colchicine 0.5 MG Oral Tablet - COVID - 19 | Phase 1 / Phase 2 | Completed | Zaeema Kanwal | 66 | 2025-02-24 | 2025-09-04 |
| The Effect of Colchicine on Platelet Function Profiles in Patients With Stable Coronary Artery Disease Colchicine 0.5 MG oral tablet twice daily - Coronary Artery Disease | Phase 1 | Completed | The University of The West Indies | 22 | 2024-08-21 | 2025-08-11 |
| Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy Carvedilol, Ramipril, Rosuvastatin - Chemotherapy Induced Systolic Dysfunction | Phase 1 | Unknown | Arab Contractors Medical Centre | 150 | 2024-05-01 | 2024-03-12 |
| Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Colchicine - HFpEF - Heart Failure With Preserved Ejection Fraction, Colchicine | Phase 1 / Phase 2 | Completed | I.M. Sechenov First Moscow State Medical University | 42 | 2022-12-15 | 2026-04-23 |
| Study to Evaluate the Safety of Colchicine oral colchicine(0.6 mg) once a day - Radiation Therapy | Phase 1 | Active not recruiting | Rutgers, The State University of New Jersey | 30 | 2022-05-10 | 2026-05-20 |
| Colchicine Effect on Perivascular Inflammation Index on Coronary CTA Colchicine - Atherosclerosis, Inflammatory Response | Phase 1 | Unknown | University of Sao Paulo General Hospital | 40 | 2022-03-07 | 2022-05-09 |
| Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors Colchicine - Urothelial Cancer, Metastatic Solid Tumor | Phase 1 | Completed | Icahn School of Medicine at Mount Sinai | 16 | 2022-02-14 | 2024-12-27 |
| To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout Colchicine - Gout | Phase 1 | Unknown | The Affiliated Hospital of Qingdao University | 20 | 2021-10-18 | 2022-05-09 |
| Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection Colchicine 0.5 MG - COVID-19 Pandemic | Phase 1 | Completed | University of Baghdad | 160 | 2021-04-01 | 2021-12-09 |
| Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19) Colchicine - Covid19 | Phase 1 / Phase 2 | Terminated | Baptist Health South Florida | 2 | 2020-12-23 | 2022-07-25 |
| Revisiting the Mechanism of the Anti-inflammatory Effect of Colchicine Colchicine Tablets, Placebo oral tablet - Colchicine Mechanism of Action | Phase 1 | Unknown | Brigham and Women's Hospital | 18 | 2020-05-06 | 2022-03-16 |
| The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout Colchicine, Febuxostat, SHR4640 - Gout | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 15 | 2017-02-17 | 2019-08-08 |
| Colchicine for Diabetic Nephropathy Trial Colchicine, Placebo - Diabetic Nephropathies | Phase 1 / Phase 2 | Unknown | Sheba Medical Center | 40 | 2016-02-22 | 2017-05-09 |
| Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome Colchicine 0.6Mg Cap, Placebo capsules given, Colchicine 0.6Mg Tab - Obesity, Metabolic Disease | Phase 1 / Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 77 | 2014-05-31 | 2019-08-13 |
| Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients cyclosporine+colchicine, tacrolimus - Renal Replacement Therapies | Phase 1 | Completed | Assistance Publique - Hôpitaux de Paris | 17 | 2010-05-01 | 2013-04-11 |
| Bioavailability Study of Colcrys® in Apple Juice colchicine 0.6 mg tablet - Healthy | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 16 | 2010-05-01 | 2011-05-03 |
| Bioavailability Study of Colcrys® Crushed and Sprinkled on Applesauce Colchicine 0.6 mg tablet - Healthy | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 16 | 2010-05-01 | 2011-05-12 |
| Relative Bioavailability of Colcrys™ 0.6 mg Tablets in Healthy Young and Elderly Volunteers Under Fasted Conditions Colcrys™ (colchicine) - Healthy | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 38 | 2009-10-01 | 2010-09-28 |
| Drug-Food Interaction Study of Seville Orange Juice and Colchicine Colchicine, Seville Orange Juice - Healthy | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 24 | 2009-02-01 | 2011-06-08 |
| Drug-Drug Interaction Study Between Colchicine and Atorvastatin Colchicine, Atorvastatin - Healthy | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 24 | 2009-02-01 | 2010-03-30 |
Showing 20 of 35. Sign in to see all of them.
COVID-19 (3) · Gout (2) · Inflammation (2) · Atherosclerosis (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Dermatitis (1) · Diabetic Nephropathies (1) · Dyslipidemias (1) · Fasting (1) · Fibrosis (1) · Gastrointestinal Diseases (1) · Lecithin Cholesterol Acyltransferase Deficiency (1) · Liver Cirrhosis (1) · Metabolic Diseases (1)
Mutual Pharmaceutical Company, Inc. (19) · Arab Contractors Medical Centre (1) · Assistance Publique - Hôpitaux de Paris (1) · Baptist Health South Florida (1) · Brigham and Women's Hospital (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · I.M. Sechenov First Moscow State Medical University (1) · Icahn School of Medicine at Mount Sinai (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · National Center for Research Resources (NCRR) (1) · Rutgers, The State University of New Jersey (1) · Sheba Medical Center (1) · The Affiliated Hospital of Qingdao University (1) · The University of The West Indies (1) · University of Baghdad (1)
United States (22) · China (2) · Brazil (1) · Egypt (1) · France (1) · Iraq (1) · Israel (1) · Pakistan (1) · Russia (1) · Trinidad and Tobago (1)
Anthony R Godfrey, Pharm.D. (7) · Anthony R Godfrey, PharmD (2) · Darin B Brimhall, D.O. (2) · Ahmed S Abdulamir, MD (1) · Anastasia Shchendrygina (1) · Anthony R G, Pharm.D. (1) · Antoine Jacquet, MD (1) · Bruce Haffty, MD (1) · Deborah Doroshow (1) · Eslam Abbas, MBChB, MSc (1) · Jack A Yanovski, M.D. (1) · Lindsey Baden, MD (1) · Matthew Davis, M.D. (1) · Matthew Davis, MD (1) · Naveen Seecheran (1)
PMID 21480191, PMID 22940371, PMID 22913907, PMID 24452746, PMID 30869182, PMID 30937899, PMID 31740368, PMID 32863171, PMID 34658014, PMID 37586845, PMID 39826082
ZIAHD000641-23 (1)